BSE Live
Nov 14, 16:01Prev. Close
9204.10
Open Price
9185.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:46Prev. Close
9183.00
Open Price
9170.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
9153.00 (9)
| Cash Flow of AstraZeneca Pharma (in Rs. Cr.) | Dec 09 | Dec 08 | Dec 07 | Dec 06 | Dec 05 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 88.39 | 114.38 | 95.35 | 74.95 | 64.78 | |
| Net CashFlow From Operating Activities | 32.57 | 81.65 | 39.71 | 54.62 | 28.09 | |
| Net Cash Used In Investing Activities | 2.19 | 5.26 | -2.70 | -2.46 | -4.16 | |
| Net Cash Used From Financing Activities | -110.88 | -54.14 | -33.97 | -11.30 | -28.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -76.12 | 32.77 | 3.03 | 40.85 | -4.08 | |
| Cash And Cash Equivalents Begin of Year | 143.80 | 111.04 | 108.00 | 67.15 | 71.22 | |
| Cash And Cash Equivalents End Of Year | 67.68 | 143.80 | 111.04 | 108.00 | 67.15 |
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
10.11.2025
31.07.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y